Accuray Incorporated's CEO to Speak at 27th Annual JP Morgan Healthcare Conference

Wednesday, December 31, 2008 General News J E 4
SUNNYVALE, Calif., Dec. 30 Accuray Incorporated(Nasdaq: ARAY), a global leader in the field of radiosurgery, announced todaythat its president and chief executive officer, Euan S. Thomson, Ph.D., isscheduled to present at the 27th Annual JP Morgan Healthcare Conference in SanFrancisco, on Wednesday, January 14, 2009 at 11:30 a.m. PST (2:30 p.m. EST).

A live webcast of the presentation will be available online from theinvestor relations page of the Company's Web site at webcast replay of the presentation will begin approximately one hour afterthe conclusion of the live presentation and will be available forapproximately 30 days.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only roboticradiosurgery system designed to treat tumors anywhere in the bodynon-invasively. Using continual image guidance technology and computercontrolled robotic mobility, the CyberKnife System automatically tracks,detects and corrects for tumor and patient movement in real-time throughoutthe treatment. This enables the CyberKnife System to deliver high-doseradiation with pinpoint precision, which minimizes damage to surroundinghealthy tissue and eliminates the need for invasive head or body stabilizationframes.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is aglobal leader in the field of radiosurgery dedicated to providing an improvedquality of life and a non-surgical treatment option for those diagnosed withcancer. Accuray develops and markets the CyberKnife Robotic RadiosurgerySystem, which extends the benefits of radiosurgery to include extracranialtumors, including those in the spine, lung, prostate, liver and pancreas. Todate, the CyberKnife System has been used to treat more than 50,000 patientsworldwide and currently more than 150 systems have been installed in leadinghospitals in the Americas, Europe and Asia. For more information, please visit

SOURCE Accuray Incorporated


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
GlaxoSmithKline Reduces Minimum Tender Condition a...
Aduromed Announces Retirement of Vice Chairman and...